THE ROLE OF HIGH-QUALITY GENERICS IN THE TREATMENT OF CHRONIC DISEASES – STADA Pymepharco joins hands with pharmacists in the Central Vietnam through a series of scientific seminars.
On October 1, 2025, STADA Pymepharco officially launched a series of scientific and educational seminars on Generics in Tuy Hoa (Dak Lak). The opening event welcomed 200+ pharmacists and featured expert presentations, including from Assoc. Prof. Dr. Truong Van Tuan – Standing Deputy Chairman of the Ho Chi Minh City Pharmaceutical Association.
👉 The program centers on the critical role of high-quality Generics in the treatment of chronic diseases, while providing updates on stringent quality requirements under both Vietnamese regulations and international standards such as EMA (Europe).
💊 With two EU-GMP certified manufacturing sites in Dak Lak, each with annual capable of over 1.2 million units per shift, STADA Pymepharco not only meets domestic demand but also qualifies to export to the most highly regulated markets, including Europe. The company is among Vietnam’s leading pharmaceutical manufacturers in terms of EU-GMP lines, and one of only two companies nationwide to operate all 03 EU-GMP certified production lines for non-beta & beta-lactam (tablets/injectables) and beta-lactam tablets,
🌍 As the sole wholly-owned affiliate of STADA Group in Vietnam – a leading German pharmaceutical company present in 100+ countries – #STADAPymepharco is committed to bringing “German-standard” medicines to patients and consumers in Vietnam, while expanding to international markets.
✨ Through this seminar series, STADA Pymepharco aims to raise awareness of the importance of high-quality Generics, reaffirming our commitment to provide trusted treatment options for healthcare professionals and better health for Vietnamese patients.
📍 Following Dak Lak, the event series continue in Quang Ngai (October 2) and Khanh Hoa (October 4) – we look forward to engaging with pharmacists at the next stops in Central Vietnam!
#STADAPymepharco #GermanStandard #EUGMP
| |||||||||||||||
Read more about STADA Pymepharco: | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
